(Q31425931)

2 July 2017

1 reference

title

Endogenous neurotoxins from tryptophan (English)

1 reference

2 July 2017

Stone TW

1

0 references

publication date

1 January 2001

1 reference

2 July 2017

1 reference

2 July 2017

39

1 reference

2 July 2017

61-73

1 reference

2 July 2017

1

1 reference

Macrophage Activation Factors in the Brains of AIDS Patients

2 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Kynurenine metabolism in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Temporal and spatial changes of quinolinic acid immunoreactivity in the gerbil hippocampus following transient cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid in children with congenital hyperammonemia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Chronic intrastriatal quinolinic acid produces reversible changes in perikaryal calbindin and parvalbumin immunoreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid in vivo synthesis rates, extracellular concentrations, and intercompartmental distributions in normal and immune-activated brain as determined by multiple-isotope microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Neurochemical characterization of excitotoxin lesions in the cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Role of kynurenines in the neurotoxic actions of kainic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid accumulation and functional deficits following experimental spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid accumulation in injured spinal cord: time course, distribution, and species differences between rat and guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Differential sensitivity of neuropeptide Y, somatostatin and NADPH-diaphorase containing neurons in rat cortex and striatum to quinolinic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid and lymphocyte subsets in the intrathecal compartment as biomarkers of SIV infection and simian AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Increase in kynurenic acid in Huntington's disease motor cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

The effect of kainic, quinolinic and beta-kainic acids on the release of endogenous amino acids from rat brain slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Elevated plasma kynurenine in Tourette syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, cinnabarinate, quinolinate and picolinate

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Glucose metabolism and hemoglobin reactivity in human red blood cells exposed to the tryptophan metabolites 3-hydroxyanthranilate, quinolinate and picolinate

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Activated human microglia produce the excitotoxin quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Temporal and spatial changes of quinolinic acid immunoreactivity in the immune system of lipopolysaccharide-stimulated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Chronic infusion of quinolinic acid in rat striatum: effects on discrete neuronal populations

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinate and kainate neurotoxicity in neostriatal cultures is potentiated by co-culturing with neocortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Neuroactive kynurenines in Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and L-kynurenine in acute septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Delayed increases in regional brain quinolinic acid follow transient ischemia in the gerbil.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Metal-mediated oxidative damage to cellular and isolated DNA by certain tryptophan metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Modulation of quinolinic acid-induced depletion of striatal NADPH diaphorase and enkephalinergic neurons by inhibition of nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Neurocytotoxity of quinolinic acid in human brain cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Neurotoxic effect induced by quinolinic acid in dissociated cell culture of mouse hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinate neurotoxicity in cortical cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Depletion of systemic macrophages by liposome-encapsulated clodronate attenuates increases in brain quinolinic acid during CNS-localized and systemic immune activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Cultured striatal neurons containing NADPH-diaphorase or acetylcholinesterase are selectively resistant to injury by NMDA receptor agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

The possible contribution of microglia and macrophages to delayed neuronal death after ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Neuronal injury associated with HIV-1: approaches to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Neurochemical and metabolic consequences of elevated cerebrospinal fluid quinolinic acid concentrations in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Subchronic intraventricular infusion of quinolinic acid produces working memory impairment--a model of progressive excitotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Antibodies to quinolinic acid reveal localization in select immune cells rather than neurons or astroglia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Kynurenic acid is present in the rat brain and its content increases during development and aging processes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

No changes in central quinolinic acid levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Viral load and its relationship to quinolinic acid, TNF alpha, and IL-6 levels in the CNS of retroviral infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

3-Hydroxykynurenine toxicity on the rat striatum in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Free radical scavenger OPC-14117 attenuates quinolinic acid-induced NF-kappaB activation and apoptosis in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Metabolism of L-tryptophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Kynurenine pathway abnormalities in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

An investigation of the activities of 3-hydroxykynureninase and kynurenine aminotransferase in the brain in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Determination of 3-hydroxykynurenine in human brain and plasma by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid: regional variations in neuronal sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Altered tryptophan metabolism in mice with herpes simplex virus encephalitis: increases in spinal cord quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Increased brain 3-hydroxykynurenine in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Brain quinolinic acid in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid is a potent lipid peroxidant in rat brain homogenates

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. I. Comparison of the effects of various excitotoxins, with particular reference to the loss of immunohistochemically identified cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Effects of N omega-nitro-L-arginine and L-arginine on quinolinic acid-induced lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Increased Concentrations of the Neurotoxin 3-Hydroxykynurenine in the Frontal Cortex of HIV-1-Positive Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid levels in a murine retrovirus-induced immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Excitant activity of methyl derivatives of quinolinic acid on rat cortical neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Subtypes of NMDA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Inhibitors of the kynurenine pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

NMDA receptors and ligands in the vertebrate CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid and other kynurenines in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Movement disorder following excitotoxin lesions in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Immuno-electron microscopy reveals that the excitotoxin quinolinate is associated with the plasma membrane in human peripheral blood monocytes/macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Monoamine metabolites in the cerebrospinal fluid in infantile spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Extracellular levels of quinolinic acid are moderately increased in rat neostriatum following severe insulin-induced hypoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

A glycine antagonist 7-chlorokynurenic acid attenuates ischemia-induced learning deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Energetic dysfunction in quinolinic acid-lesioned rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Virus isolation and quinolinic acid in primary and chronic simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Increased quinolinate immunoreactivity in the peripheral blood monocytes/macrophages from SIV-infected monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

Quinolinic acid in neurological disease: opportunities for novel drug discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2800%2900156-2

7 January 2021

10.1016/S0041-0101(00)00156-2

Identifiers

DOI

1 reference

2 July 2017

1 reference

PubMed ID

10936623